Skip to content

Member

Sirpa PIETIKÄINEN

EPP · Finland

Group
EPP PPE
Country
Finland
Roll-call participation
89.6 %ⓘ of 5 503 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
85.0 %ⓘ of 4 932 votes where the group had a line · EPP median 93.6 %
More facts (5)
National party
KOK Kansallinen Kokoomus
In office
Since 1 Dec 2024
Against clear line
664 of 4 722 votesⓘ
Committees
ECON, ENVI (substitute), FEMM, SANT (substitute)
Member id
40599
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

89.6 %

4 932 of 5 503 roll calls while in office

EPP median: 89.9 % (−0.3 pts)

Chamber median: 90.2 %

With majority line ⓘ

85.0 %

4 194 of 4 932 votes where their group had a line

EPP median: 93.6 % (−8.6 pts)

Against clear line ⓘ

14.1 %

664 of 4 722 votes where their group had a clear line

610 opposite (for ↔ against), 44 abstained against the line, 10 voted for or against when the line was to abstain

Abstention ⓘ

1.1 %

55 of 4 932 votes cast

Participation 89.6 % — EPP median 89.9 %, 196 members.ⓘ
Data as a table
Participation among the 196 members of the EPP with enough votes.
FigureParticipation
Sirpa PIETIKÄINEN89.6 %
EPP median89.9 %
Lowest in the group17.0 %
Highest in the group99.6 %
Members196
With majority line 85.0 % — EPP median 93.6 %, 196 members.ⓘ
Data as a table
With majority line among the 196 members of the EPP with enough votes.
FigureWith majority line
Sirpa PIETIKÄINEN85.0 %
EPP median93.6 %
Lowest in the group70.2 %
Highest in the group99.5 %
Members196
  • Whole term, 5 928 roll-call votes. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 572

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
11 Mar 2026Recommendation on enhanced EU-Canada cooperation in the current geopolitical context, including the threats to Canada’s economic stability and sovereignty Adopted 482 for, 108 against, 42 abstainedPosition: For Majority line: For
11 Mar 2026Tackling barriers to the single market for defence Adopted 393 for, 169 against, 67 abstainedPosition: For Majority line: For
11 Mar 2026Flagship European defence projects of common interest Adopted 448 for, 122 against, 38 abstainedPosition: For Majority line: For
10 Mar 2026Harmonising certain aspects of insolvency law Passed 498 for, 90 against, 28 abstainedPosition: For Majority line: For
10 Mar 2026Establishing an EU talent pool Passed 414 for, 182 against, 21 abstainedPosition: For Majority line: For
10 Mar 2026Increased efficiency of the External Action Guarantee Passed 441 for, 105 against, 81 abstainedPosition: For Majority line: For
10 Mar 2026European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2023 and 2024 Adopted 493 for, 92 against, 44 abstainedPosition: For Majority line: For
10 Mar 2026Housing crisis in the European Union with the aim of proposing solutions for decent, sustainable and affordable housing Adopted 367 for, 166 against, 84 abstainedPosition: For Majority line: For
10 Mar 2026Public access to documents - report 2022 - 2024 Adopted 602 for, 9 against, 8 abstainedPosition: For Majority line: For
10 Mar 2026Copyright and generative artificial intelligence – opportunities and challenges Adopted 460 for, 71 against, 88 abstainedPosition: For Majority line: For
10 Mar 2026Fisheries management approaches for safeguarding sensitive species, tackling invasive species and benefiting local economies Adopted 528 for, 21 against, 62 abstainedPosition: For Majority line: For
10 Mar 2026The upcoming European Research Area (ERA) Act Adopted 399 for, 78 against, 69 abstainedPosition: For Majority line: For
24 Feb 2026Four years of Russia’s war of aggression against Ukraine and European contributions to a just peace and sustained security for Ukraine Adopted 437 for, 82 against, 70 abstainedPosition: For Majority line: For
12 Feb 2026Cooperation among enforcement authorities regarding unfair trading practices in the agri-food supply chain Passed 555 for, 0 against, 26 abstainedPosition: For Majority line: For
12 Feb 2026Post-election situation in Uganda and threats against opposition leader Bobi Wine Adopted 514 for, 3 against, 56 abstainedPosition: For Majority line: For
12 Feb 2026Systemic oppression, inhumane conditions and arbitrary detentions by the regime in Iran Adopted 524 for, 3 against, 41 abstainedPosition: For Majority line: For
12 Feb 2026Targeted expulsions of foreign journalists and foreign Christians in Türkiye under national security pretexts Adopted 502 for, 2 against, 59 abstainedPosition: For Majority line: For
12 Feb 2026Developing a new EU anti-poverty strategy Adopted 385 for, 141 against, 53 abstainedPosition: For Majority line: For
12 Feb 2026Addressing subcontracting chains and the role of intermediaries in order to protect workers’ rights Adopted 332 for, 209 against, 33 abstainedPosition: For Majority line: For
12 Feb 2026Recommendation to the Council on EU priorities for the 70th session of the UN Commission on the Status of Women Adopted 340 for, 141 against, 68 abstainedPosition: For Majority line: For
12 Feb 2026Situation in Northeast Syria, the violence against civilians and the need to maintain a sustainable ceasefire Adopted 363 for, 71 against, 81 abstainedPosition: For Majority line: For
11 Feb 2026Regulation implementing enhanced cooperation on the establishment of the Ukraine Support Loan for 2026 and 2027 Passed 458 for, 140 against, 44 abstainedPosition: For Majority line: For
11 Feb 2026Amending Regulation (EU) 2024/792 establishing the Ukraine Facility Passed 473 for, 140 against, 32 abstainedPosition: For Majority line: For
11 Feb 2026Amending the multiannual financial framework for the years 2021 to 2027 Consent given 490 for, 130 against, 32 abstainedPosition: For Majority line: For
11 Feb 2026Mobilisation of the European Globalisation Adjustment Fund: application EGF/2025/006 BE/Audi – Belgium Passed 593 for, 55 against, 9 abstainedPosition: For Majority line: For
11 Feb 2026Genetically modified soybean DBN-09004-6 Objection passed 461 for, 169 against, 22 abstainedPosition: For Majority line: Against
11 Feb 2026Genetically modified maize T25 (ACS-ZMØØ3-2) Objection passed 462 for, 169 against, 22 abstainedPosition: For Majority line: Against
11 Feb 2026Genetically modified cotton T304-40 Objection passed 428 for, 156 against, 22 abstainedPosition: For Majority line: Against
11 Feb 2026Genetically modified cotton GHB614 × LLCotton25 Objection passed 463 for, 164 against, 21 abstainedPosition: For Majority line: Against
11 Feb 2026Interim report in view of the consent procedure on the Agreement establishing an association between the EU and the Principality of Andorra and the Republic of San Marino Interim report adopted 552 for, 24 against, 75 abstainedPosition: For Majority line: For
11 Feb 2026EU strategic defence and security partnerships Adopted 440 for, 119 against, 85 abstainedPosition: For Majority line: For
10 Feb 2026Establishment of a list of safe countries of origin at Union level Passed 408 for, 184 against, 60 abstainedPosition: Abstained ≠ groupMajority line: For
10 Feb 2026Application of the ‘safe third country’ concept Passed 396 for, 226 against, 30 abstainedPosition: Abstained ≠ groupMajority line: For
10 Feb 2026Amending regulations on agricultural products as regards market rules and sectoral support measures in the wine sector and for aromatised wine products Passed 625 for, 15 against, 11 abstainedPosition: For Majority line: For
10 Feb 2026Amending the Measuring Instruments Directive Passed 594 for, 25 against, 23 abstainedPosition: For Majority line: For
10 Feb 2026Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products Passed 483 for, 102 against, 67 abstainedPosition: For Majority line: For
10 Feb 2026Framework for achieving climate neutrality Passed 413 for, 226 against, 12 abstainedPosition: No vote recorded Majority line: For
10 Feb 2026European Union designs (codification) Passed 613 for, 5 against, 29 abstainedPosition: For Majority line: For
10 Feb 2026European Central Bank – annual report 2025 Adopted 443 for, 71 against, 117 abstainedPosition: For Majority line: For
22 Jan 2026Motion of censure on the Commission Rejected 165 for, 390 against, 10 abstainedPosition: Against Majority line: Against
22 Jan 2026Conviction and imminent sentencing of Jimmy Lai in Hong Kong Adopted 503 for, 9 against, 100 abstainedPosition: For Majority line: For
22 Jan 2026Case of Joseph Figueira Martin in the Central African Republic Adopted 582 for, 0 against, 35 abstainedPosition: For Majority line: For
22 Jan 2026Drones and new systems of warfare – the EU’s need to adapt to be fit for today’s security challenges Adopted 483 for, 68 against, 76 abstainedPosition: For Majority line: For
22 Jan 2026Choice of performance indicators for audit and budgetary control in the context of financing measures to support the implementation of future European competitiveness Adopted 318 for, 247 against, 67 abstainedPosition: For Majority line: For
22 Jan 2026European technological sovereignty and digital infrastructure Adopted 471 for, 68 against, 71 abstainedPosition: For Majority line: For
22 Jan 2026Brutal repression against protesters in Iran Adopted 562 for, 9 against, 57 abstainedPosition: For Majority line: For
22 Jan 2026Attempted takeover of Lithuania’s public broadcaster and the threat to democracy in Lithuania Adopted 385 for, 165 against, 35 abstainedPosition: For Majority line: For
21 Jan 2026Air passenger rights Amendments 1 + 243 (voted as one) adopted 632 for, 15 against, 9 abstainedPosition: For Majority line: For
21 Jan 2026EU-Bosnia and Herzegovina Agreement on operational activities carried out by the European Border and Coast Guard Agency in Bosnia and Herzegovina Consent given 565 for, 83 against, 14 abstainedPosition: For Majority line: For
21 Jan 2026Enhanced cooperation on the establishment of a Loan for Ukraine Consent given 499 for, 135 against, 24 abstainedPosition: For Majority line: For

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 31 of 88 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Willemien KONING EPPNetherlands87 % of 1 811 shared89 %
Aura SALLA EPPFinland87 % of 4 053 shared89 %
Axel VOSS EPPGermany86 % of 3 754 shared89 %
Isabel WISELER-LIMA EPPLuxembourg86 % of 4 796 shared89 %
Liesbet SOMMEN EPPBelgium86 % of 4 836 shared89 %
Marie-Sophie CHRIST EPPGermany86 % of 1 392 shared89 %
Manuela RIPA EPPGermany86 % of 4 456 shared89 %
Sandra KALNIETE EPPLatvia85 % of 4 619 shared89 %
Martine KEMP EPPLuxembourg85 % of 4 347 shared89 %
Verena MERTENS EPPGermany85 % of 4 277 shared89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Ľudovít ÓDOR RenewSlovakia89 % of 4 580 shared82 %
Yvan VEROUGSTRAETE RenewBelgium89 % of 3 540 shared82 %
Veronika CIFROVÁ OSTRIHOŇOVÁ RenewSlovakia88 % of 3 700 shared82 %
Martin HOJSÍK RenewSlovakia88 % of 4 419 shared82 %
Lucia YAR RenewSlovakia88 % of 4 880 shared82 %
Katarina BARLEY S&DGermany88 % of 3 672 shared75 %
Iratxe GARCÍA PÉREZ S&DSpain88 % of 4 627 shared75 %
Brigitte VAN DEN BERG RenewNetherlands88 % of 4 104 shared82 %
Michal WIEZIK RenewSlovakia88 % of 4 465 shared82 %
Dainius ŽALIMAS RenewLithuania88 % of 4 547 shared82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Economic and Monetary AffairsECON CommitteeMember16 Dec 2024now
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute20 Jan 2025now
Committee on Women’s Rights and Gender EqualityFEMM CommitteeMember16 Dec 2024now
Committee on Public HealthSANT CommitteeSubstitute23 Jan 2025now
Delegation for relations with the People's Republic of ChinaD-CN DelegationSubstitute2 Dec 2024now
Delegation for relations with the Pan-African ParliamentDPAP DelegationMember16 Dec 2024now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on Children’s RightsIG10-06 Intergroup / working groupMember19 Feb 2025now
Intergroup on DisabilityIG10-10 Intergroup / working groupMember11 Mar 2025now
Intergroup on Fighting against PovertyIG10-12 Intergroup / working groupMember17 Jun 2025now

Show all 18 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Neurological health strategyShadow rapporteurSANT20 Jul 2026
Union Civil Protection Mechanism and Union support for health emergency preparedness and response, and repealing Decision No 1313/2013/EU (Union Civil Protection Mechanism)Shadow rapporteurSANT23 Apr 2026
Safety, resilience and sustainability of space activities in the UnionShadow rapporteur for an opinionENVI3 Nov 2025
Collection of statistical information by the European Central BankShadow rapporteurECON24 Sept 2025
Developing a new EU anti-poverty strategyShadow rapporteur for an opinionFEMM25 Jun 2025
Gender inequalities in health, specifically as regards gender-specific conditionsShadow rapporteur for an opinionSANT25 Jun 2025

Show all 6 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

23 contributions recorded, 16 written statements; 12 minutes of speaking time.

Show all 23 recent contributions

Questions and motions, 75

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
8 Sept 2026Chatbots directing women with unwanted pregnancies to anti-abortion websites E-10-2026-003539Written questionwith 67 co-authorsNot yet answered
2 Sept 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize MON 87460 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0381Motion for a resolutionwith 3 co-authors—
2 Sept 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean GMB151 x DAS-44406-6 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0380Motion for a resolutionwith 3 co-authors—
2 Sept 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 94313 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0379Motion for a resolutionwith 3 co-authors—
16 Jul 2026Ensuring the continued operation of the Blue Flag Programme under Directive (EU) 2024/825 E-10-2026-003031Written questionwith 29 co-authors18 Sept 2026
8 Jul 2026Impact of the recent US Supreme Court ruling on the EU–US Data Privacy Framework and European data sovereignty E-10-2026-002823Written questionwith 21 co-authorsNot yet answered
1 Jul 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87705 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0334Motion for a resolutionwith 3 co-authors—
1 Jul 2026MOTION FOR A RESOLUTION on the draft Commission Implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP202216 x NK603 x DAS-40278-9 and its sub-combinations DP202216 x NK603, DP202216 x DAS-40278-9, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0336Motion for a resolutionwith 3 co-authors—
1 Jul 2026MOTION FOR A RESOLUTION on the Commission Implementing Decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize NK603 × T25 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0335Motion for a resolutionwith 3 co-authors—
29 Jun 2026Scrutiny of hunting trophy imports into the EU E-10-2026-002689Written questionwith 8 co-authors25 Aug 2026
22 Jun 2026Ensuring that people with hearing and visual impairments can access the information provided in emergency communications E-10-2026-002572Written question3 Sept 2026
11 Jun 2026Forced sterilisation of women with disabilities – data and safeguards in institutional settings E-10-2026-002420Written questionwith 7 co-authors22 Sept 2026
11 Jun 2026EU funding for institutional care – data and safeguards E-10-2026-002417Written questionwith 10 co-authorsNot yet answered
11 Jun 2026EU-funded deinstitutionalisation reforms in Romania and implementation of person-centred financing E-10-2026-002419Written questionwith 8 co-authors1 Sept 2026
8 Jun 2026Transposition of the directive on the protection of the environment through criminal law E-10-2026-002347Written questionwith 2 co-authors20 Jul 2026
4 Jun 2026Revision of Regulation (EC) No 1099/2009 and phase-out of CO₂ stunning of pigs E-10-2026-002317Written questionwith 12 co-authors21 Aug 2026
12 May 2026Stakeholder involvement and evidence-based decision-making regarding the Fur Free Europe citizens’ initiative E-10-2026-001966Written questionwith 11 co-authors9 Jul 2026
24 Apr 2026Fiscal guidance on the treatment of interest-subsidised loans for affordable housing in public debt E-10-2026-001687Written questionwith 8 co-authors29 Jun 2026
22 Apr 2026Establishing criteria for shipments of waste for disposal E-10-2026-001648Written question6 Jul 2026
21 Apr 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 94637 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0186Motion for a resolutionwith 3 co-authors—
15 Apr 2026Repeated human rights violations by Israel E-10-2026-001531Written questionNot yet answered
31 Mar 2026Fourth Protocol on Environmental Crimes to UNTOC E-10-2026-001325Written questionwith 9 co-authors6 Jul 2026
11 Feb 2026Protecting allergic consumers by harmonising EU ingredient labelling E-10-2026-000591Written questionwith 5 co-authors17 Apr 2026
5 Feb 2026When and how will the Commission deliver on its commitment to revise the EU’s animal welfare legislation? O-10-2026-000006Oral questionwith 35 co-authorsNot yet answered
4 Feb 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified cotton GHB614 × LLCotton25 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0109Motion for a resolutionwith 3 co-authors—
4 Feb 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified cotton T304-40 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0108Motion for a resolutionwith 3 co-authors—
4 Feb 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for placing on the market of products containing, consisting of or produced from genetically modified maize T25 (ACS-ZMØØ3-2) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0106Motion for a resolutionwith 3 co-authors—
4 Feb 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean DBN-09004-6 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0107Motion for a resolutionwith 3 co-authors—
3 Feb 2026Ensuring patient safety for all Europeans: the need to establish a warning system for disqualified medical professionals E-10-2026-000428Written questionwith 24 co-authors27 Mar 2026
19 Jan 2026Compatibility of the Finnish Hunting Act with EU legal protection requirements and the Habitats Directive E-10-2026-000196Written questionwith 5 co-authors17 Mar 2026
15 Jan 2026Transparency on Commission workshops linked to the ‘Fur Free Europe’ European Citizens’ Initiative E-10-2026-000164Written question16 Mar 2026
19 Dec 2025Whale and dolphin hunting in the Faroe Islands E-10-2025-005028Written questionwith 33 co-authors30 Mar 2026
16 Dec 2025Welfare of wild animals E-10-2025-004965Written questionwith 6 co-authors12 Feb 2026
16 Dec 2025Pesticide information on food labels E-10-2025-004958Written questionwith 1 co-author19 Mar 2026
15 Dec 2025MOTION FOR A RESOLUTION on the draft Commission regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetamiprid, aclonifen, deltamethrin, oxathiapiprolin and potassium phosphonates in or on certain products B-10-2025-0592Motion for a resolutionwith 4 co-authors—
9 Dec 2025MOTION FOR A RESOLUTION on the draft Commission Implementing Decision authorising the placing on the market of food, food ingredients and feed produced from genetically modified sugar beet KWS20-1 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2025-0559Motion for a resolutionwith 3 co-authors—
9 Dec 2025MOTION FOR A RESOLUTION on the draft Commission Implementing Decision of renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize NK603 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2025-0562Motion for a resolutionwith 3 co-authors—
26 Nov 2025Recommendation on harmful practices E-10-2025-004697Written questionwith 14 co-authors18 Feb 2026
12 Nov 2025Commission representation at CITES CoP20 E-10-2025-004477Written question27 Jan 2026
11 Nov 2025Commission contribution to the 2025 global fund replenishment E-10-2025-004455Written questionwith 24 co-authors4 Mar 2026
23 Oct 2025Sliding scale for steel (Ecodesign for Sustainable Products Regulation and the proposed industrial decarbonisation accelerator act) E-10-2025-004184Written questionwith 18 co-authors19 Dec 2025
22 Oct 2025The ongoing disinformation campaign targeting the United Nations Relief and Works Agency for Palestine refugees in the Near East and the EU’s support to the agency E-10-2025-004158Written questionwith 41 co-authors25 Mar 2026
13 Oct 2025Ambition and scope of the upcoming revision of on-farm animal welfare legislation E-10-2025-004010Written questionwith 7 co-authors16 Dec 2025
13 Oct 2025Letter regarding the announcement by the Dutch Government to postpone the transposition of the Pay Transparency Directive to 2027 E-10-2025-004018Written questionwith 28 co-authors18 Dec 2025
24 Sept 2025MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP51291 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2025-0407Motion for a resolutionwith 3 co-authors—
24 Sept 2025Fur farming and the placing of farmed fur products on the market O-10-2025-000034Oral questionwith 40 co-authorsNot yet answered
23 Sept 2025Newborn screening for access to advanced life-saving therapies E-10-2025-003675Written questionwith 3 co-authors21 Nov 2025
22 Sept 2025Non-discrimination between home-based care and institutional care for persons with disabilities in Commission policies and competencies E-10-2025-003653Written questionwith 5 co-authors28 Nov 2025
15 Sept 2025Environmental impact of medicines and reuse of unused cytotoxic drugs E-10-2025-003538Written questionwith 3 co-authors8 Dec 2025
23 Jul 2025Update of guidelines to combat greenwashing in accordance with Directive (EU) 2024/825 E-10-2025-003053Written questionwith 8 co-authors4 Sept 2025
17 Jul 2025Violations of the Animal Transport Regulation E-10-2025-002984Written questionwith 8 co-authors4 Sept 2025
17 Jul 2025Legal clarification on the status of farm animals taken in by shelters, sanctuaries or private individuals E-10-2025-002950Written questionwith 12 co-authors16 Sept 2025
4 Jul 2025The abuse of state advertising for political influence and enforcement of the European Media Freedom Act (EMFA) E-10-2025-002736Written questionwith 23 co-authors28 Aug 2025
2 Jul 2025MOTION FOR A RESOLUTION on the Commission delegated regulation of 10 June 2025 amending Delegated Regulation (EU) 2016/1675 to add Algeria, Angola, Côte d’Ivoire, Kenya, Laos, Lebanon, Monaco, Namibia, Nepal and Venezuela to the list of high-risk third countries which have provided a written high-level political commitment to address the identified deficiencies and have developed an action plan with the FATF, and to remove Barbados, Gibraltar, Jamaica, Panama, the Philippines, Senegal, Uganda and the United Arab Emirates from that list B-10-2025-0318Motion for a resolutionwith 48 co-authors—
27 Jun 2025New studies confirming carcinogenic effects of long-term exposure to glyphosate at relevant levels E-10-2025-002611Written questionwith 31 co-authorsNot yet answered
26 Jun 2025Methodical killing of stray animals in Romania and potential misuse of EU funds E-10-2025-002593Written questionwith 10 co-authors4 Sept 2025
24 Jun 2025Future EU care deal E-10-2025-002533Written questionwith 1 co-author8 Aug 2025
4 Jun 2025Authorisation of available treatments for feline infectious peritonitis (FIP) E-10-2025-002247Written questionwith 9 co-authors20 Aug 2025
28 May 2025Urgent activation of the EU Blocking Statute, as requested by Parliament in its 2024 annual report on human rights and democracy in the world E-10-2025-002163Written questionwith 21 co-authors30 Jul 2025
27 May 2025Israel’s intention to take full control of the Gaza strip and remove the Palestinian population from the area – EU’s actions and reactions E-10-2025-002127Written questionwith 24 co-authors1 Aug 2025
21 May 2025Mandatory use of AI-based tools on social media platforms to detect new child sexual abuse material E-10-2025-002018Written question23 Jul 2025
20 May 2025Mink farming and the protection of animal welfare E-10-2025-002013Written questionwith 7 co-authors30 Jul 2025
15 May 2025The slaughter of marine mammals in the Faroe Islands E-10-2025-001959Written questionwith 13 co-authors8 Jul 2025
30 Apr 2025The EU marine action plan and the missing national roadmaps E-10-2025-001732Written question2 Jul 2025
28 Apr 2025Animal welfare standards in EU aquaculture to boost competitiveness and food security E-10-2025-001689Written questionwith 15 co-authors30 Jul 2025
28 Apr 2025Per- and polyfluoroalkyl substances (PFAS) and endocrine-disrupting chemicals (EDCs) E-10-2025-001693Written questionwith 30 co-authors2 Jul 2025
14 Apr 2025MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87705 × MON 87708 × MON 89788 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2025-0244Motion for a resolutionwith 3 co-authors—
2 Apr 2025Abolition of seasonal clock changes in the EU and follow-up actions by the Commission E-10-2025-001369Written questionwith 22 co-authors28 Jul 2025
1 Apr 2025Withdrawal of the Horizontal Anti-Discrimination Directive P-10-2025-001330Priority written questionwith 40 co-authors21 May 2025
19 Mar 2025Seizing the Russian shadow fleet in the Baltic Sea: the Commission’s measures to prevent vessel sales E-10-2025-001174Written questionwith 60 co-authors29 Jul 2025
18 Mar 2025Withdrawal of the proposed horizontal anti-discrimination directive P-10-2025-001148Priority written questionwith 46 co-authors24 Jul 2025
13 Mar 2025Concerns about the European Food Safety Authority’s risk assessment of soy leghemoglobin E-10-2025-001090Written questionwith 4 co-authors18 Jun 2025
5 Mar 2025The need to scale up the EU’s efforts to combat environmental crime E-10-2025-000923Written questionwith 2 co-authors19 May 2025
21 Feb 2025Commission’s response to the incomplete implementation of the UN Convention on the Rights of Persons with Disabilities in Member States E-10-2025-000810Written questionwith 50 co-authors27 May 2025
19 Feb 2025EU action and leadership on global health in view of the US withdrawal from the World Health Organization (WHO) P-10-2025-000773Priority written questionwith 33 co-authors14 May 2025

Amendments tabled in committee, 126

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT43
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT21
31 Jul 2026on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791136 ECON4
31 Jul 2026on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791135 ECON39
31 Jul 2026on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791103 ECON3
31 Jul 2026on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791134 ECON9
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT3
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT1
27 Jul 2026on the proposal for a directive of the European Parliament and of the Council amending Directives 2009/65/EC, 2011/61/EU and 2014/65/EU as regards the further development of capital market integration and supervision within the Union ECON-AM-791126 ECON1
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953 CJ531

Show all 126 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Finland National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Sirpa PIETIKÄINEN”. Member record. memberId 40599. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/40599?docs=all&page=5&rows=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/40599. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/40599?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-40599,
  author = {{EU Parl Watch Research}},
  title = {{Sirpa PIETIKÄINEN}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/40599?docs=all&page=5&rows=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/40599?docs=all&page=5&rows=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 40599. Official source: https://www.europarl.europa.eu/meps/en/40599. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}